Long-term Effects of Modest Weight Loss in Type II Diabetic Patients

1987 ◽  
Vol 147 (10) ◽  
pp. 1749 ◽  
Author(s):  
Rena R. Wing
2003 ◽  
Vol 4 (2) ◽  
pp. 84
Author(s):  
M. Rafiei ◽  
M. Boshtam ◽  
I. Golshadi ◽  
M. Ani

2001 ◽  
Vol 8 (5) ◽  
pp. 503-510 ◽  
Author(s):  
Frank R. Arko ◽  
Geoffrey D. Rubin ◽  
Bonnie L. Johnson ◽  
Bradley B. Hill ◽  
Thomas J. Fogarty ◽  
...  
Keyword(s):  
Type Ii ◽  

2009 ◽  
Vol 90 (1) ◽  
pp. 23-32 ◽  
Author(s):  
Grant D Brinkworth ◽  
Manny Noakes ◽  
Jonathan D Buckley ◽  
Jennifer B Keogh ◽  
Peter M Clifton

1986 ◽  
Vol 398 (2) ◽  
pp. 221-230 ◽  
Author(s):  
Eric S. Nisenbaum ◽  
Edward M. Stricker ◽  
Michael J. Zigmond ◽  
Theodore W. Berger

2001 ◽  
Vol 16 (3) ◽  
pp. 186-190 ◽  
Author(s):  
K.N. Roy Chengappa ◽  
J. Levine ◽  
D. Rathore ◽  
H. Parepally ◽  
R. Atzert

SummaryTopiramate is an antiepileptic agent, which is being investigated as a mood-stabilizer. Three obese individuals with DSM-IV bipolar I disorder and type II diabetes mellitus received topiramate treatment in combination with antipsychotics and valproate or carbamazepine. In addition to improved mood stability, these individuals lost between 16 to 20.5% of their pre-topiramate body weight and also achieved significant glycemic control.


2014 ◽  
Vol 25 (3) ◽  
pp. 397-405 ◽  
Author(s):  
Cristian Ricci ◽  
Maddalena Gaeta ◽  
Emanuele Rausa ◽  
Emanuele Asti ◽  
Francesco Bandera ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document